oa Journal of Endocrinology, Metabolism and Diabetes in South Africa - ActosTM maintains effective long-term glucose control in type 2 diabetes - : advertorial

Volume 10, Issue 2
  • ISSN : 1608-9677
  • E-ISSN: 2220-1009



Extracted from text ... A review of 4-year data of clinic patients with type 2 diabetes who had continuously received ActosTM (pioglitazone) 30 or 45 mg/day and no other thiazolinidiones shows that treatment with ActosTM was associated with sustained and progressive reduction of hypoglycaemia over that treatment period.1 In addition, after combination with ActosTM, the dose of other concomitant antidiabetic medications, including sulphonylureas, metformin and insulin, could be reduced during the first year of treatment and maintained for the entire 4 years. In many type 2 diabetics treated with other oral antihypoglycaemic agents, glycaemic control often deteriorates as a consequence of progressive loss ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error